Liberate Bio

Liberate Bio is a genetic medicine company developing in vivo cell therapies that reach cell populations beyond the liver, the long-standing limit of lipid nanoparticle delivery. Its RAPTOR discovery platform is a scalable in vivo screening system that identifies LNP delivery vehicles which work with existing biology to carry genetic payloads into immune cells in blood, bone marrow, and the spleen. Liberate Bio applies that delivery capability to in vivo CAR-M (chimeric antigen receptor macrophage) programs, reprogramming monocytes and macrophages to eliminate disease-driving cells without ex vivo manipulation, with programs in hematologic oncology and in autoimmune disease via depletion of pathogenic B-cell populations. Founded by Nessan Bermingham, Theresa M. Reineke, and Michael Mitchell, and led by CEO Shawn Davis and CSO Walter Strapps, the company raised $31M from Khosla Ventures in October 2025. It is pre-clinical and publishes no public API or developer surface.

Liberate Bio is profiled on the APIs.io network. Tagged areas include Company, Biotechnology, Genetic Medicine, Cell Therapy, and Oncology.

🌐 Visit website 📡 Source on GitHub

7.7/100 minimal ▬ flat Agent 0/100 human only Full breakdown ↓
scored 2026-07-27 · rubric v0.5

0 APIs

CompanyBiotechnologyGenetic MedicineCell TherapyOncologyAutoimmune DiseaseDrug DiscoveryLife Sciences

Kin Score

Kin Score How this is scored →
scored 2026-07-27 · rubric v0.5

Composite quality — 7.7/100 · minimal

Contract Quality 0.0 / 25

Developer Ergonomics 0.0 / 20

Commercial Clarity 0.0 / 20

Operational Transparency 0.0 / 13

Governance 0.0 / 12

Discoverability 6.8 / 10

Agent readiness — 0/100 · human only

Machine-Readable Contract 0 / 18

Agentic Access Contract 0 / 15

MCP Server 0 / 12

Machine-Readable Auth 0 / 10

Idempotency 0 / 9

Stable Error Semantics 0 / 8

Request/Response Examples 0 / 7

Rate-Limit Signaling 0 / 7

Typed Event Surface 0 / 6

Agent Skills 0 / 5

Well-Known Catalog 0 / 4

Consent & Bot Identity 0 / 3

Improve this rating by publishing the missing artifacts — every area above can be raised, and the full rubric is at apis.io/rating/. This rating is computed from github.com/api-evangelist/liberatebio: open an issue to ask a question, or submit a pull request to add artifacts. Want it done for you? Prioritized profiling — $2,500 →

Agent Surfaces 1

MCP servers, agent skills, and machine-readable catalogs

LLMsTxt

LLMsTxt

Access & Security 1

Authentication, authorization, and security posture

DomainSecurity

DomainSecurity

Operate 1

Status, limits, changes, and where to get help

Contact

Contact

Company 3

The organization behind the API

Website

Website

About

About

LinkedIn

Other 1

Properties that don't map to a standard resource type

Platform

Platform

Source (apis.yml)

aid: liberatebio
name: Liberate Bio
description: Liberate Bio is a genetic medicine company developing in vivo cell therapies that reach cell populations beyond
  the liver, the long-standing limit of lipid nanoparticle delivery. Its RAPTOR discovery platform is a scalable in vivo screening
  system that identifies LNP delivery vehicles which work with existing biology to carry genetic payloads into immune cells
  in blood, bone marrow, and the spleen. Liberate Bio applies that delivery capability to in vivo CAR-M (chimeric antigen
  receptor macrophage) programs, reprogramming monocytes and macrophages to eliminate disease-driving cells without ex vivo
  manipulation, with programs in hematologic oncology and in autoimmune disease via depletion of pathogenic B-cell populations.
  Founded by Nessan Bermingham, Theresa M. Reineke, and Michael Mitchell, and led by CEO Shawn Davis and CSO Walter Strapps,
  the company raised $31M from Khosla Ventures in October 2025. It is pre-clinical and publishes no public API or developer
  surface.
accessModel:
  pricing: unknown
  onboarding: unknown
  trial: false
  try_now: false
  public: false
  label: Unknown
  confidence: low
  source: []
  generated: '2026-07-22'
  method: derived
image: https://cdn.prod.website-files.com/67e3bde7b915febd27c1c697/67eac222ce05837cb0310a11_Liberate%20Bio%20Logo%20Horizonta%20(White)%20Ver-2.png
url: https://raw.githubusercontent.com/api-evangelist/liberatebio/refs/heads/main/apis.yml
x-type: company
x-source: vc-portfolio
x-backed-by:
- khosla-ventures
x-tier: stub
x-tier-reason: no-public-api
specificationVersion: '0.20'
created: '2026-07-17'
modified: '2026-07-19'
tags:
- Company
- Biotechnology
- Genetic Medicine
- Cell Therapy
- Oncology
- Autoimmune Disease
- Drug Discovery
- Life Sciences
apis: []
maintainers:
- FN: Kin Lane
  email: kin@apievangelist.com
- FN: APIs.json
  email: info@apis.io
common:
- type: Website
  url: https://www.liberatebio.com/
- type: About
  url: https://www.liberatebio.com/about-us
- type: Platform
  url: https://www.liberatebio.com/platform
- type: Contact
  url: https://www.liberatebio.com/contact-us
- type: LinkedIn
  url: https://www.linkedin.com/company/liberate-bio/
- type: DomainSecurity
  url: security/liberatebio-domain-security.yml
- type: LLMsTxt
  url: llms/liberatebio-llms.txt
x-enrichment:
  date: '2026-07-19'
  status: backfilled
  pass: local-v1
  note: backfilled from .gitignore signal + verified work evidence